Status:
TERMINATED
A Randomised Single Centre Study to Compare the Long-term Performance of 4 Designs of the DePuy Ultima LX Stem in Primary Total Hip Replacement
Lead Sponsor:
DePuy International
Conditions:
Osteoarthritis
Post-traumatic Arthritis
Eligibility:
All Genders
60-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the performance of 4 designs of the DePuy Ultima LX hip stem in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who...
Eligibility Criteria
Inclusion
- Current indications for primary total hip arthroplasty utilising a cemented femoral component. These include pain, deformity and loss of function which are not responsive to medical treatment
Exclusion
- i) Revision Total Hip Arthroplasty ii) Rheumatoid arthritis iii) Age greater than 80 years at time of surgery iv) Age less than 60 years at time of surgery v) Previous hip joint sepsis vi) Obesity vii) Patient likely to remain housebound once rehabilitation is complete
Key Trial Info
Start Date :
May 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT00208351
Start Date
May 1 1997
End Date
March 1 2015
Last Update
May 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Epsom General Hospital
Surrey, United Kingdom, KT18 7EG